Latest News

04.18.19

US Military Develops Mobile Application to Treat Eye Injuries

Source: HIT Infrastructure

04.18.19

Innovent Announces First Patient Dosed in a Phase 1 Clinical Trial of IBI302 for the Treatment of Wet AMD

Source: Innovent Biologics

04.16.19

Ophthotech Changes Name to Iveric bio as it Transitions to Gene Therapy Company

Source: Ophthotech

04.16.19

Proxy Advisory Firms Back Allergan in Battle with Dissident Shareholder Appaloosa

Source: FirstWord

04.16.19

Oertli Upgrades its Faros Compact Surgical Platform

Source: Oertli Instrumente

04.15.19

Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab for Wet AMD

Source: Novartis

04.15.19

Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases

Source: Ophthotech

04.11.19

Alimera Sciences Appoints Samer Kaba, MD, as Chief Medical Officer

Source: Alimera Sciences

04.10.19

US Ophthalmologists Push to Remove Roadblocks to Patients’ Access to Medical and Surgical Eye Care

Source: American Academy of Ophthalmology

04.10.19

Texas Tech Medical School to End Use of Race in Admissions

Source: NPR

View more stories